Mucinex Fast-max Tablet, Coated
Pricing Report NDC 63824-193-20

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Mucinex Fast-max Severe Congestion And Cough (NDC 63824-193-20) is $0.51228 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 01, 2019.

As a a human over the counter drug provided by Reckitt Benckiser Llc, this medication is distributed in a 2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.51228
Per EA

Effective Date
Mar 01, 2019
Billable Units
2 EA
Estimated Package Price
$1.02
Data Status
As of Mar 11, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 BLISTER PACK in 1 CARTON / 10 TABLET, COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.49150 to $0.52234 per EA. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4915 - $0.5223
Market Volatility
6.27% Variance
Latest Trend
4.23%
Date Unit Price Unit Source Method Rate
Mar 01, 2019 $0.51228 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Mar 01, 2019 $0.51228 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Feb 20, 2019 $0.49150 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 20, 2016 $0.52234 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 20, 2016 $0.52234 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Apr 20, 2016 $0.52234 EAC/I - Chain or Independent PharmacyCode 3, 6B - Brand
Apr 20, 2016 $0.52234 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026